These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30802989)

  • 1. PNPLA3, CGI-58, and Inhibition of Hepatic Triglyceride Hydrolysis in Mice.
    Wang Y; Kory N; BasuRay S; Cohen JC; Hobbs HH
    Hepatology; 2019 Jun; 69(6):2427-2441. PubMed ID: 30802989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation.
    BasuRay S; Smagris E; Cohen JC; Hobbs HH
    Hepatology; 2017 Oct; 66(4):1111-1124. PubMed ID: 28520213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patatin-like phospholipase domain–containing protein 3 promotes transfer of essential fatty acids from triglycerides to phospholipids in hepatic lipid droplets.
    Mitsche MA; Hobbs HH; Cohen JC
    J Biol Chem; 2018 May; 293(18):6958-6968. PubMed ID: 29555681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of PNPLA3 on lipid droplets is the basis of associated hepatic steatosis.
    BasuRay S; Wang Y; Smagris E; Cohen JC; Hobbs HH
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9521-9526. PubMed ID: 31019090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hepatitis C virus core protein inhibits adipose triglyceride lipase (ATGL)-mediated lipid mobilization and enhances the ATGL interaction with comparative gene identification 58 (CGI-58) and lipid droplets.
    Camus G; Schweiger M; Herker E; Harris C; Kondratowicz AS; Tsou CL; Farese RV; Herath K; Previs SF; Roddy TP; Pinto S; Zechner R; Ott M
    J Biol Chem; 2014 Dec; 289(52):35770-80. PubMed ID: 25381252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of adipose triglyceride lipase protects from hepatic endoplasmic reticulum stress in mice.
    Fuchs CD; Claudel T; Kumari P; Haemmerle G; Pollheimer MJ; Stojakovic T; Scharnagl H; Halilbasic E; Gumhold J; Silbert D; Koefeler H; Trauner M
    Hepatology; 2012 Jul; 56(1):270-80. PubMed ID: 22271167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis.
    Li JZ; Huang Y; Karaman R; Ivanova PT; Brown HA; Roddy T; Castro-Perez J; Cohen JC; Hobbs HH
    J Clin Invest; 2012 Nov; 122(11):4130-44. PubMed ID: 23023705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans.
    Borén J; Adiels M; Björnson E; Matikainen N; Söderlund S; Rämö J; Henricsson M; Ripatti P; Ripatti S; Palotie A; Mancina RM; Ainola M; Hakkarainen A; Romeo S; Packard CJ; Taskinen MR
    J Intern Med; 2022 Feb; 291(2):218-223. PubMed ID: 34411351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic patatin-like phospholipase domain-containing 3 levels are increased in I148M risk allele carriers and correlate with NAFLD in humans.
    Ericson E; Bergenholm L; Andréasson AC; Dix CI; Knöchel J; Hansson SF; Lee R; Schumi J; Antonsson M; Fjellström O; Nasr P; Liljeblad M; Carlsson B; Kechagias S; Lindén D; Ekstedt M
    Hepatol Commun; 2022 Oct; 6(10):2689-2701. PubMed ID: 35833455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patatin-like phospholipase domain-containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease.
    Chen W; Chang B; Li L; Chan L
    Hepatology; 2010 Sep; 52(3):1134-42. PubMed ID: 20648554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth retardation, impaired triacylglycerol catabolism, hepatic steatosis, and lethal skin barrier defect in mice lacking comparative gene identification-58 (CGI-58).
    Radner FP; Streith IE; Schoiswohl G; Schweiger M; Kumari M; Eichmann TO; Rechberger G; Koefeler HC; Eder S; Schauer S; Theussl HC; Preiss-Landl K; Lass A; Zimmermann R; Hoefler G; Zechner R; Haemmerle G
    J Biol Chem; 2010 Mar; 285(10):7300-11. PubMed ID: 20023287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis.
    He S; McPhaul C; Li JZ; Garuti R; Kinch L; Grishin NV; Cohen JC; Hobbs HH
    J Biol Chem; 2010 Feb; 285(9):6706-15. PubMed ID: 20034933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein.
    Romeo S; Huang-Doran I; Baroni MG; Kotronen A
    Curr Opin Lipidol; 2010 Jun; 21(3):247-52. PubMed ID: 20480550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein.
    Johnson SM; Bao H; McMahon CE; Chen Y; Burr SD; Anderson AM; Madeyski-Bengtson K; Lindén D; Han X; Liu J
    Nat Commun; 2024 Jun; 15(1):4847. PubMed ID: 38844467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic interactions of ABHD5 with PNPLA3 regulate triacylglycerol metabolism in brown adipocytes.
    Yang A; Mottillo EP; Mladenovic-Lucas L; Zhou L; Granneman JG
    Nat Metab; 2019 May; 1(5):560-569. PubMed ID: 31497752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Hepatic Triacylglycerol Metabolism by CGI-58 Does Not Require ATGL Co-activation.
    Lord CC; Ferguson D; Thomas G; Brown AL; Schugar RC; Burrows A; Gromovsky AD; Betters J; Neumann C; Sacks J; Marshall S; Watts R; Schweiger M; Lee RG; Crooke RM; Graham MJ; Lathia JD; Sakaguchi TF; Lehner R; Haemmerle G; Zechner R; Brown JM
    Cell Rep; 2016 Jul; 16(4):939-949. PubMed ID: 27396333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression level of non-alcoholic fatty liver disease-related gene PNPLA3 in hepatocytes is highly influenced by hepatic lipid status.
    Hoekstra M; Li Z; Kruijt JK; Van Eck M; Van Berkel TJ; Kuiper J
    J Hepatol; 2010 Feb; 52(2):244-51. PubMed ID: 20015565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bile acids induced hepatic lipid accumulation in mice by inhibiting mRNA expression of patatin-like phospholipase domain containing 3 and microsomal triglyceride transfer protein.
    Hashimoto N; Han KH; Wakagi M; Ishikawa-Takano Y; Ippoushi K; Fukushima M
    Nutr Res; 2021 Aug; 92():12-20. PubMed ID: 34174520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro.
    Pirazzi C; Adiels M; Burza MA; Mancina RM; Levin M; Ståhlman M; Taskinen MR; Orho-Melander M; Perman J; Pujia A; Andersson L; Maglio C; Montalcini T; Wiklund O; Borén J; Romeo S
    J Hepatol; 2012 Dec; 57(6):1276-82. PubMed ID: 22878467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis.
    Smagris E; BasuRay S; Li J; Huang Y; Lai KM; Gromada J; Cohen JC; Hobbs HH
    Hepatology; 2015 Jan; 61(1):108-18. PubMed ID: 24917523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.